Who will remain in management roles at Irvine?Yes, Irvine is not ideal as a location because of cost but it willl survive this first round after integration...Pfizer's CEO is on record saying they want to keep the talent in the therapeutic areas allergan competes. Site closure is not the issue. Will you like the role, your new management structure, culture those are the concerns at least for the next 18 months.
The handful of management that Pfizer wants to keep can be easily relocated. Irvine is not needed at all and nearly all non-management staff will lose their jobs through site closure as this is the logical cost-cutting choice that will cheer shareholders at both Pfizer and Allergan.Yes, Irvine is not ideal as a location because of cost but it willl survive this first round after integration...Pfizer's CEO is on record saying they want to keep the talent in the therapeutic areas allergan competes. Site closure is not the issue. Will you like the role, your new management structure, culture those are the concerns at least for the next 18 months.
Spot on.The handful of management that Pfizer wants to keep can be easily relocated. Irvine is not needed at all and nearly all non-management staff will lose their jobs through site closure as this is the logical cost-cutting choice that will cheer shareholders at both Pfizer and Allergan.
Botox is made in Ireland. Botox research will relocate to Ireland and Irvine shut down completely.Ofcourse 3000+ plus employees working on BOTOX and eye care will just get on a ship and cruise to New York! you know its not like BOTOX is big or anything!
You have no clue what you are talking about, I would just say that your statement is not accurate. Dont want to talk too much on a public forum. you also don't seem to understand what it takes to do research and how 'easy' it is to move to a different part of the country let alone a different continent.Botox is made in Ireland. Botox research will relocate to Ireland and Irvine shut down completely.
You have no clue what you are talking about, I would just say that your statement is not accurate. Dont want to talk too much on a public forum. you also don't seem to understand what it takes to do research and how 'easy' it is to move to a different part of the country let alone a different continent.
The handful of management that Pfizer wants to keep can be easily relocated. Irvine is not needed at all and nearly all non-management staff will lose their jobs through site closure as this is the logical cost-cutting choice that will cheer shareholders at both Pfizer and Allergan.
Yes, Irvine is not ideal as a location because of cost but it willl survive this first round after integration...Pfizer's CEO is on record saying they want to keep the talent in the therapeutic areas allergan competes. Site closure is not the issue. Will you like the role, your new management structure, culture those are the concerns at least for the next 18 months.